According to MarketsandMarkets™, the Prefilled Syringes Market is projected to grow from about USD 8.65 billion in 2026 to ...

As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

According to MarketsandMarkets, "Protective Films Market by Type [Pressure-Sensitive Adhesive (PSA) Films, Non-adhesive/Cling ...

ANI Pharmaceuticals' growth pivots to Cortrophin Gel as retina headwinds weigh on 2025, with 2026 recovery hopes hinging on ...

The warning was issued over the drops that were sold nationwide in stores including Walgreens, Kroger and H-E-B.

In an interview, Chief Financial Officer Robin Kramer said the combined cash flow from Biogen and Apellis will not only help ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion, a move that would expand its presence in complement-mediated diseases, including ...

The majority of atopic dermatitis (AD) patients with hand and/or foot (H&F) involvement experienced clearance over 12 months of treatment with ADBRY(R) (tralokinumab-ldrm)/ADTRALZA(R) (tralokinumab).1 ...

Stakeholders are being encouraged to weigh in on the European Chemicals Agency (ECHA) 60-day public consultation period related to a planned ban on per-and-polyfluoroalkyl (PFAS) substances, also ...

Chief Financial Officer Robin Kramer explained how the deal not only provides two marketed products, but a team with ...

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements ...